"From Down Under to Duke" - Glioblastoma AKA GBM - S.2 Ep.14

David M. Ashley, PhD, FRACP, MBBS (Hons), Director of the Preston Robert Tisch Brain Tumor Center at Duke joins us on this episode to discuss his history in neuro-oncology, innovations happening at the Brain Tumor Center, clinical trial advancements, and his past-life as a surfer. On this episode, you'll hear us chat about:
- What led him to Duke
- The world-renown Duke Polio clinical trial & it's comeback
- His work in discovering how scientists can learn to prevent brain tumors
- The brain & it's own lymphatic system
- How research is translated from in-vitro to in-vivo
-& so much more
TO LEARN MORE ABOUT THE ORGANIZATION VISIT GBMRESEARCH.ORG.
Trigger warnings may include: cancer, cancer treatment, clinical trials, scientific terminology, and realizing that this episode may have taught you more in 39 minutes than any of your high school science classes did.
SEASON SPONSORS: BIODEXA PHARMACEUTICALS, GAMMA TILE, NOVOCURE, AND ROON.
As always, the information that is discussed in Glioblastoma AKA GBM is not meant to treat, diagnose, or prevent any disease. What we and our guests share are personal stories of what has worked for the individuals in question, and should not be taken as medical advice or opinion, and is not a substitute for medical advice. If you have any questions about your own situation, always consult with your medical provider and healthcare team.

[@damianferguson2388]

Great stuff. Love getting an update from the duke docs. With love from a Aussie with an oligodenglioma. Keep up the great work

[@nikbarclay7282]

All talk. No evidence of new significant drugs to beat the current standard of care TMZ. GBM agile? Never heard of it.

[@glioblastomaresearch]

GBM Agile is a trial currently being led by GCAR: Global Coalition of Adaptive Research. You can learn more by visiting www.gcaresearch.org/research/gbm-agile/